Sign up to save your podcasts
Or
Share Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure | JACC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure | JACC
In this episode, Dr. Valentin Fuster discusses a study on sodium zirconium cyclosilicate (SZC) for managing hyperkalemia in heart failure patients on mineralocorticoid receptor antagonists (MRAs) like spironolactone. While SZC effectively reduced hyperkalemia and allowed higher spironolactone doses, concerns over worsening heart failure events highlight the complex balance between treatment benefits and risks.
View all episodes
By American College of Cardiology
4.2
161161 ratings
In this episode, Dr. Valentin Fuster discusses a study on sodium zirconium cyclosilicate (SZC) for managing hyperkalemia in heart failure patients on mineralocorticoid receptor antagonists (MRAs) like spironolactone. While SZC effectively reduced hyperkalemia and allowed higher spironolactone doses, concerns over worsening heart failure events highlight the complex balance between treatment benefits and risks.
More shows like JACC This Week
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
498 Listeners
This Week in Cardiology
885 Listeners
JACC Specialty Journals
18 Listeners
Circulation on the Run
31 Listeners
The Curbsiders Internal Medicine Podcast
3,344 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
140 Listeners
Core IM | Internal Medicine Podcast
1,156 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
61 Listeners
ACC CardiaCast
41 Listeners
Annals On Call Podcast
195 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
The Curious Clinicians
371 Listeners